Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease
- Creator: Tong, Koliarne , Barker, Daniel , France, Megan , Burr, Lucy , Greville, Hugh , Visser, Simone , Middleton, Peter , Wainwright, Claire , Dorahy, Douglas , Wark, Peter
- Resource Type: journal article
- Date: 2020
Lumacaftor/ Ivacaftor improves ese tolerance in patients with cystic fibrosis and severe airflow obstructionxerci
- Creator: Wark, Peter A. B. , Cookson, Kim , Thiruchelvam, Theeba , Brannan, John , Dorahy, Douglas J.
- Resource Type: journal article
- Date: 2019
An "unlikely" pair: the antimicrobial synergy of polymyxin B in combination with the cystic fibrosis transmembrane conductance regulator drugs KALYDECO and ORKAMBI
- Creator: Schneider, Elena K. , Azad, Mohammad A. K. , Muller, Mark T. , Li, Jian , Velkov, Tony , Han, Mei-Ling , Zhou, Qi (Tony) , Wang, Jiping , Huang, Johnny X. , Cooper, Matthew A. , Doi, Yohei , Baker, Mark A. , Bergen, Phillip J.
- Resource Type: journal article
- Date: 2016